Test ID: SLO
Smith-Lemli-Opitz Screen, Plasma
Method Description
Describes how the test is performed and provides a method-specific reference
The plasma specimen is hydrolyzed with 2% KOH/ethanol for 1 hour at 65 degrees C. The compounds are then extracted with hexane, followed by evaporation to dryness under nitrogen. Using 50:50 50 bis-(trimethylsilyl) trifluoroacetamide (BSTFA:pyridine), the sterols are derivatized to generate trimethylsilyl ethers. The derivatized specimens are then transferred to gas chromatography (GC) sampling vials and 2 mcL are injected onto a HP-5 capillary column. Selected ion-monitoring electron impact gas chromatography-mass spectrometry is used as qualitative screening. When 7-dehydrocholesterol (7-DHC) and 8-DHC are detected in abnormal concentrations (>2 mcg/mL), quantitative analysis is performed via gas chromatography with flame ionization detection using epi-coprostanol as the internal standard.(Kelley RI: Diagnosis of Smith-Lemli-Opitz syndrome by gas chromatography/mass spectrometry of 7-dehydrocholesterol in plasma, amniotic fluid and cultured skin fibroblasts. Clin Chim Acta 1995;236:45-58)
Day(s) and Time(s) Test Performed
Outlines the days and times the test is performed. This field reflects the day and time the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time required before the test is performed. Some tests are listed as continuously performed, which means assays are performed several times during the day.
Varies; Batched 1 time per week


